The News Feed


Dry Eye in Diabetes Linked to Protective, Risk Factors

Female sex, older age and poor diabetic control, among others, increased the prevalence, while certain meds reduced it.
September 14, 2022

Study Assesses Risk Factors of Poor Visual Outcomes Post-vitrectomy

Baseline VA, tractional membrane and silicone oil tamponade correlated with logMAR VA at one year in diabetes patients.
September 2, 2022

Ultra-widefield Imaging Identifies DR Risk Factors

Peripheral lesions and nonperfusion were independently associated with disease worsening.
August 26, 2022

Blood Test Finding Correlates with DR Risk

Lower levels of neutrophil-to-lymphocyte ratio reflect systemic inflammation and a positive association with the condition.
August 22, 2022

Steroid Implant More Effective than Anti-VEGF for DME

It was, however, found to be have higher rates of complications in a recent study.
August 12, 2022

Study Identifies Predictors of Vitrectomy Outcomes in DME

Vessel density, foveal avascular zone and central retinal thickness are among the parameters to watch out for.
August 11, 2022

One-time Gene Therapy Injection for DR Shows Promise

The interim phase II results found that almost half of the patients achieved at least a two-step improvement in severity at six months.
July 27, 2022

Retinal Neurodegeneration, Choroidal Thinning Progress in Diabetes

Rates were significantly faster in incident DR.
July 22, 2022

Choriocapillaris Flow Deficit Can Predict DR Progression

Circulatory alterations here and in retinal layers can also track DME development.
July 21, 2022

Starting DME Therapy with Eylea or Avastin Yields Similar Outcomes

A new study suggests that step therapy beginning with off-label bevicizumab, which significantly reduces cost, likely has no deleterious impact on treatment efficacy.
July 19, 2022